Using Flexible Cohort
Management to Enable
Creativity in Oncology
Designs

Regulatory agencies are becoming more flexible about accepting positive results, allowing trial sponsors to be more creative with oncology designs. The challenge is that most clinical systems such as RTSM are not flexible enough to adapt to mid-study changes without trial disruption.

Download this postion paper to learn:

• How flexible cohort management can enable complex oncology designs
• 5 key capabilities of cohort management necessary to support creativity
• Importance of both control and flexibility in cohort management
• Benefits of an integrated supply forecasting engine to reduce overage